您的位置：首页 > 产品中心 > 1246430-02-3， 13:0 Lyso PI
13:0 Lyso PI
| 产品编号： | 4095385 |
| 规格： | 1-tridecanoyl-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol) (ammonium salt), powder |
| CAS NO： | 1246430-02-3 |
| 包装规格： | 100 μG，500 μG |
| 产品类别： | 进口试剂 |
| 品牌： | Avanti |
| 优惠价： | 立即咨询 |
产品别名
1246430-02-3
13:0 Lyso PI
PI(13:0/0:0); 110716
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C22H46NO12P |
| Molecular weight | 547.57 |
| NACRES | NA.25 |
| General description【一般描述】 | Lysophosphatidylinositol (LPI), produced by phospholipase A2 is a bioactive lipid. |
| Application【应用】 | 13:0 Lyso PI (1-tridecanoyl-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol) may be used as a nonendogenous phospholipid (PL) standard for the quantitative analysis of PLs. It may also be used as a standard for tandem mass spectrometry analysis of lipid species in human plasma. |
| Biochem/physiol Actions【生化/生理作用】 | Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent ligand for the G-protein-coupled receptor GPR55. Lysophosphatidylinositol (LPI) is expected to play a vital role in various diseases. Ca2+ channels at the plasma membrane and mitochondrial membrane are controlled by LPI. It can also stimulate various signaling pathways to control several cellular processes. LPI can block the migration of cells. |
产品性质
| Assay【测定】 | >99% (LPI; may contain up to 10% of the 2-LPI isomer, TLC) |
| form【形式】 | powder |
| manufacturer/tradename | Avanti Polar Lipids 850101P |
| shipped in【运输】 | dry ice |
| storage temp.【储存温度】 | −20℃ |
| SMILES string | [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O)=O)(O)COC(CCCCCCCCCCCC)=O.[NH4+] |
| packaging【包装】 | 2 mL Amber Serum Vial with Stopper and Crimp Cap (850101P-100ug) 2 mL Amber Serum Vial with Stopper and Crimp Cap (850101P-500ug) |
安全信息
| Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |
